Heavy Data Science Startup, Tempus, Brings in $200 Million in New Funding

Tempus, a health technology building massive data sets of cancer-related information, knowledge-bases, has acquired an additional $200 million in funding. This injection of cash brings the Chicago based startup’s valuation to $3.1 billion and is reportedly intended to permit increased growth and the investigation of additional pathologies, such as diabetes and depression. With moves like this, Tempus seems like it’s worth watching. Read More at Forbes